Tech Company Financing Transactions
Phenomix Sciences Funding Round
Phenomix Sciences closed a $7.8 million venture capital round on 5/16/2024. Investors included Dexcom, Health2047 Capital Partners and LabCorp.
Transaction Overview
Company Name
Announced On
5/16/2024
Transaction Type
Venture Equity
Amount
$7,800,000
Round
Undisclosed
Proceeds Purpose
This capital will accelerate the commercialization and adoption of the MyPhenome� test in the obesity specialist market and the wider industry. The funds will also enable the company to develop and launch additional phenotyping tests, continue to support clinical studies and patent novel insights, and further strategic relationships with pharmaceutical companies and health care providers.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
18202 Minnetonka Blvd
Wayzata, MN 55391
USA
Wayzata, MN 55391
USA
Phone
Undisclosed
Website
Email Address
Overview
Unfortunately, obesity rates have doubled in the last 20 years. Without changes, 50% of the adult population will be obese by 2030. To address the challenges, science has brought us new medications - not all of them successful and more than a few with severe side effects. While medications come and go, complications associated with surgery and diets have come and stayed.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/16/2024: HEPHAISTOS-Pharma venture capital transaction
Next: 5/16/2024: CoLab Software venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs